Sachem Head Capital Management LP
New York, NY 20 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $4.8B
- 19 holdings
- 2026 Q2
- +16.1% QoQ
- Top 5 44.7%
AUM over time
Book
| IFF, International Flavors & Fragrances | Add +5.2% | 6,844,689 | $150.65 | $1B | +335,250 | +$161M | |
| ELAN, Elanco Animal Health | Hold | 27,835,500 | $28.38 | $790M | — | — | |
| USFD, US Foods | Add +197.0% | 20,209,852 | $34.83 | $704M | +13,406,300 | +$468M | |
| OLN, Olin | Hold | 11,950,000 | $57.52 | $687M | — | — | |
| UBER, Uber | Reduce −8.8% | 4,675,000 | $41.93 | $196M | −450,000 | −$34M | |
| Post | Hold | 1,452,000 | $112.73 | $164M | — | — | |
| LIVN, Livanova | Add +54.2% | 1,734,500 | $87.43 | $152M | +609,500 | +$63M | |
| FLEX, Flextronics | Reduce −27.3% | 8,255,000 | $18.33 | $151M | −3,100,000 | −$49M | |
| KBR, KBR Inc | Add +28.3% | 2,001,300 | $47.62 | $95M | +441,300 | +$34M | |
| CVNA, Carvana | New | 370,000 | $231.79 | $86M | +370,000 | +$86M | |
| Denbury | New | 780,600 | $76.59 | $60M | +780,600 | +$60M | |
| PTON, Peloton Interactive | New | 1,645,000 | $35.76 | $59M | +1,645,000 | +$59M | |
| Pactiv Evergreen | Hold | 3,375,000 | $12.68 | $43M | — | — | |
| Triumph Group | New | 1,002,900 | $18.53 | $19M | +1,002,900 | +$19M | |
| Orion Acquisition | Hold | 500,000 | $9.85 | $4.9M | — | — | |
| Golden Arrow Merger | Hold | 375,000 | $9.81 | $3.7M | — | — | |
| Sema4 | Hold | 500,000 | $4.46 | $2.2M | — | — | |
| Holding | Hold | 200,000 | $9.91 | $2M | — | — |
Exits / last held
Gone since 2021 Q3, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| DELL, Dell Technologies | Exit | 0 | $104.04 | $260M | −2,496,644 | −$260M | |
| META, Meta Platforms | Exit | 0 | $339.39 | $192M | −564,300 | −$192M | |
| LAD, Lithia Motors | Exit | 0 | $317.04 | $134M | −422,800 | −$134M | |
| Holding | Exit | 0 | $39.28 | $68M | −1,725,265 | −$68M | |
| Constellium | Exit | 0 | $18.78 | $15M | −790,000 | −$15M | |
| CM Life Sciences III | Exit | 0 | $10.25 | $10M | −1,000,000 | −$10M | |
| Somalogic | Exit | 0 | $11.98 | $6M | −500,000 | −$6M |
Filings history
20 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 19 | $4.8B | +16.1% | 13F-HR | 8/14/2026 | 000090266426003505 |
| 2026 Q1 | 19 | $4.2B | −2.7% | 13F-HR | 5/15/2026 | 000090266426002506 |
| 2025 Q4 | 20 | $4.3B | +20.5% | 13F-HR | 2/13/2026 | 000090266426000995 |
| 2025 Q3 | 19 | $3.5B | +10.5% | 13F-HR | 11/14/2025 | 000090266425005023 |
| 2025 Q2 | 19 | $3.2B | +28.4% | 13F-HR | 8/14/2025 | 000090266425003631 |
| 2025 Q1 | 16 | $2.5B | +37.4% | 13F-HR | 5/15/2025 | 000090266425002381 |
| 2024 Q4 | 14 | $1.8B | −4.8% | 13F-HR | 2/14/2025 | 000090266425001012 |
| 2024 Q3 | 14 | $1.9B | −5.2% | 13F-HR | 11/14/2024 | 000090266424006591 |
| 2024 Q2 | 16 | $2B | −13.9% | 13F-HR | 8/14/2024 | 000090266424005129 |
| 2024 Q1 | 12 | $2.3B | +9.4% | 13F-HR | 5/15/2024 | 000090266424003602 |
| 2023 Q4 | 13 | $2.1B | −0.2% | 13F-HR | 2/14/2024 | 000090266424001712 |
| 2023 Q3 | 13 | $2.1B | −10.6% | 13F-HR | 11/14/2023 | 000090266423005546 |
| 2023 Q2 | 16 | $2.4B | +6.0% | 13F-HR | 8/14/2023 | 000090266423004438 |
| 2023 Q1 | 17 | $2.3B | −11.8% | 13F-HR | 5/15/2023 | 000090266423003081 |
| 2022 Q4 | 18 | $2.6B | −4.6% | 13F-HR | 2/10/2023 | 000090266423001481 |
| 2022 Q3 | 21 | $2.7B | −19.2% | 13F-HR | 11/14/2022 | 000090266422004867 |
| 2022 Q2 | 20 | $3.3B | −15.2% | 13F-HR | 8/12/2022 | 000090266422003935 |
| 2022 Q1 | 18 | $3.9B | −7.8% | 13F-HR | 5/13/2022 | 000090266422002932 |
| 2021 Q4 | 20 | $4.3B | +4.8% | 13F-HR | 2/11/2022 | 000090266422001546 |
| 2021 Q3 | 23 | $4.1B | — | 13F-HR | 11/12/2021 | 000090266421004921 |
About
Sachem Head Capital Management LP
20 processed 13Fs on this site, 2021 Q3 to 2026 Q2